Cascades Capital Asset Management »

Milestone Pharmaceuticals shares owned by Cascades Capital Asset Management

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Cascades Capital Asset Management from 13F filings

Historical chart of Cascades Capital Asset Management investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Cascades Capital Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Cascades Capital Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $155k 77k 2.00
2025-06-30 $130k 67k 1.94

More positions owned by Cascades Capital Asset Management

Vanguard S&P 500 ETF Equity (VOO)
Vanguard Dividend Appreciation ETF Equity (VIG)
Microsoft Corp Equity (MSFT)
Vanguard S&P 500 Value Equity (VOOV)
Apple Equity (AAPL)
Nvidia Corp Equity (NVDA)
Vanguard Growth ETF Equity (VUG)
Wisdomtree Floating Rate Treas. ETF Equity (USFR)
Vanguard Mid Cap Index ETF Equity (VO)
Alphabet Inc Class A Equity (GOOGL)
S P D R S&p 500 Etf Equity (SPY)
Vanguard International Divdend ETF Equity (VIGI)
I Shares MSCI USA Minimum Volatilty Equity (USMV)
I Shares 3-7 Year US Treas. ETF Equity (IEI)
Vanguard Value ETF Equity (VTV)

View all positions for Cascades Capital Asset Management

Top funds holding Milestone Pharmaceuticals

Adage Capital Partners GP
Propel Bio Management
OrbiMed Advisors
Simplify Asset Management
Rtw Investments
Pathstone Holdings
Morgan Stanley
Sphera Funds Management
Toronto-Dominion Bank
Affinity Asset Advisors
Boxer Capital Management
Two Sigma Investments
Lion Point Capital
Citadel Advisors
Susquehanna International

View all funds holding Milestone Pharmaceuticals